Michael Rice Biolife Solutions Inc (BLFS) insider trading activity

Michael Rice is of BIOLIFE SOLUTIONS INC. Currently has a direct ownership of 347,085 shares of BLFS, which is worth approximately $7.51 Million. The most recent transaction as insider was on Aug 14, 2022, when has been sold 504 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 347K

0% 3M change

17.3% 12M change

Total Value Held $7.51 Million

Michael Rice Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 14 2022	BUY Grant, award, or other acquisition	-	504 Added 0.14%	364,054 Common Stock
Aug 10 2022	SELL Open market or private sale	$3,962 $23.17 p/Share	171 Reduced 0.05%	363,550 Common Stock
Jul 29 2022	BUY Grant, award, or other acquisition	-	643 Added 0.18%	363,721 Common Stock
Jul 17 2022	BUY Grant, award, or other acquisition	-	779 Added 0.21%	363,078 Common Stock
Jul 03 2022	BUY Grant, award, or other acquisition	-	847 Added 0.23%	362,299 Common Stock
Jun 28 2022	SELL Open market or private sale	$13,211 $14.86 p/Share	889 Reduced 0.25%	361,452 Common Stock
Jun 19 2022	BUY Grant, award, or other acquisition	-	899 Added 0.25%	362,341 Common Stock
Jun 05 2022	BUY Grant, award, or other acquisition	-	901 Added 0.25%	361,442 Common Stock
May 27 2022	SELL Open market or private sale	$10,883 $14.53 p/Share	749 Reduced 0.21%	360,541 Common Stock
May 22 2022	BUY Grant, award, or other acquisition	-	964 Added 0.27%	361,290 Common Stock
May 13 2022	SELL Open market or private sale	$2,033 $12.32 p/Share	165 Reduced 0.05%	360,326 Common Stock
Apr 18 2022	SELL Open market or private sale	$429,196 $17.59 p/Share	24,400 Reduced 6.34%	360,491 Common Stock
Apr 13 2022	SELL Open market or private sale	$190,600 $19.06 p/Share	10,000 Reduced 2.53%	384,891 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	$19,000 $1.9 p/Share	10,000 Added 2.47%	394,891 Common Stock
Apr 12 2022	BUY Exercise of conversion of derivative security	-	57,736 Added 13.04%	384,891 Common Stock
Apr 11 2022	SELL Open market or private sale	$195,500 $19.55 p/Share	10,000 Reduced 2.97%	327,155 Common Stock
Apr 11 2022	BUY Exercise of conversion of derivative security	$19,000 $1.9 p/Share	10,000 Added 2.88%	337,155 Common Stock
Mar 29 2022	SELL Open market or private sale	$18,459 $22.24 p/Share	830 Reduced 0.25%	327,155 Common Stock
Mar 09 2022	SELL Open market or private sale	$238,100 $23.81 p/Share	10,000 Reduced 2.96%	327,985 Common Stock
Mar 09 2022	BUY Exercise of conversion of derivative security	$19,000 $1.9 p/Share	10,000 Added 2.87%	337,985 Common Stock
Mar 07 2022	SELL Open market or private sale	$238,000 $23.8 p/Share	10,000 Reduced 2.96%	327,985 Common Stock
Mar 07 2022	BUY Exercise of conversion of derivative security	$19,000 $1.9 p/Share	10,000 Added 2.87%	337,985 Common Stock
Mar 01 2022	SELL Open market or private sale	$20,784 $23.78 p/Share	874 Reduced 0.34%	257,891 Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	70,094 Added 17.57%	328,859 Common Stock
Feb 10 2022	SELL Open market or private sale	$20,272 $29.38 p/Share	690 Reduced 0.27%	258,765 Common Stock

Michael Rice

Bothell, WA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BLFS shares.

Notify only if

Value

Insider Trading

Get notified when an Biolife Solutions Inc insider buys or sells BLFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOLIFE SOLUTIONS INC

Track Activities on BLFS

Account